National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Multiple Myeloma Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Melissa Alsina, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

None

None

12/15/2008

Kenneth C. Anderson, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/13/2009

William Bensinger, MD

Amgen Inc.;
AnorMED Inc.;
Celgene Corporation;
MedImmune Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Proteolix;
PDL BioPharma, Inc.

Amgen Inc.;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

11/17/2009

J. Sybil Biermann, MD

None

None

None

None

10/29/2009

Asher Chanan-Khan, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

11/3/2009

Adam D. Cohen, MD

None

Amgen Inc.;
Celgene Corporation

None

None

7/1/2009

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation;
Takeda Pharmaceuticals North America, Inc.

None

None

9/29/2009

Benjamin Djulbegovic, MD, PhD

Millennium Pharmaceuticals, Inc.

None

None

None

9/29/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Cristina Gasparetto, MD

Celgene Corporation;
Cephalon, Inc.;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

10/6/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Carol Ann Huff, MD

None

Amgen Inc.

None

None

9/28/2009

Adetola Kassim, MD, MS

None

None

None

None

11/7/2008

Rashmi Kumar, PhD

None

None

None

None

7/1/2009

Thomas Martin, MD

       

Pending

Joan S McClure, MS

None

None

None

None

9/28/2009

Bruno C. Medeiros, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Kosan Pharmaceuticals

Celgene Corporation;
NOCR

None

None

10/9/2009

Ruby Meredith, MD, PhD

None

None

None

None

7/1/2009

Noopur Raje, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

12/15/2008

Jeffrey Schriber, MD

None

Enzon Pharmaceuticals;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Millennium Pharmaceuticals, Inc.

None

12/15/2008

Dorothy Shead, MS

None

None

None

None

9/29/2009

Seema Singhal, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/7/2009

George Somlo, MD

American BioSciences Inc.;
AstraZeneca Pharmaceuticals LP;
National Cancer Institute;
Abraxane

Bristol-Myers Squibb Company;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

11/2/2009

Keith Stockerl-Goldstein, MD

None

Celgene Corporation

None

None

7/1/2009

Guido Tricot, MD, PhD

None

None

None

None

9/29/2009

Julie M. Vose, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Abbott Laboratories;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.

None

Boehringer Ingelheim GmbH;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.

7/1/2009

Donna M Weber, MD

None

None

None

None

1/12/2009

Joachim Yahalom, MD

None

None

None

None

11/20/2009

Furhan Yunus, MD, FACP

None

None

None

None

7/10/2009

 

NCCN Website Supporters